Remove sales-marketing event
article thumbnail

Novo Nordisk blockbuster Ozempic boasts 23% sales surge in 2023

Pharmaceutical Technology

Novo Nordisk’s leading drug Ozempic (semaglutide) is forecast to demonstrate a sales growth of 23% in 2023. Ozempic’s forecast 2023 sales of $12.5bn consolidate its position as the dominant market leader, with projected sales in 2023 54% greater than closest competitor Trulicity (dulaglutide) by Eli Lilly, which anticipates sales of $8bn.

Sales 130
article thumbnail

China’s NMPA grants priority review status for Ocumension’s Zerviate NDA

Pharmaceutical Technology

Zerviate, 0.24% was compared to emedastine difumarate ophthalmic solution, 0.05%, an antihistamine, which is marketed under undeb Emadine brand name. It was also found to be safe and well-tolerated and there is no change in the proportion of patients with adverse events compared to emedastine difumarate.

Licensing 162
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Webinar: How can we develop better therapeutic antibodies?

Drug Discovery World

Join DDW for this free event ‘ Where is the opportunity in the therapeutic antibody market? ’, which is co-sponsored by Bio-Rad and Benchling. The event will take place on 30 April at 3PM BST / 4pm CEST / 10am EDT / 7am PDT. What are the main drivers and challenges for the market in the next ten years?

article thumbnail

Webinar: Innovations and opportunities in the therapeutic antibody market

Drug Discovery World

Join DDW for this free event ‘ Where is the opportunity in the therapeutic antibody market? ’, which is co-sponsored by Bio-Rad and Benchling. The event will take place on 30 April at 3PM BST / 4pm CEST / 10am EDT / 7am PDT. What are the main drivers and challenges for the market in the next ten years?

article thumbnail

Life Science Marketers: How to Connect Content to B2B Revenue Growth

XTalks

Content marketing not only builds trust and credibility but also helps in driving brand awareness which attracts potential customers. Life science companies can position themselves as authoritative sources, create a community of loyal followers and influence purchasing decisions by leveraging content marketing strategies.

article thumbnail

Where is the opportunity in the therapeutic antibody market?

Drug Discovery World

Join DDW for this free event ‘ Where is the opportunity in the therapeutic antibody market? ’, which is co-sponsored by Bio-Rad and Benchling. The event will take place on 30 April at 3PM BST / 4pm CEST / 10am EDT / 7am PDT. What are the main drivers and challenges for the market in the next ten years?

article thumbnail

Where is the opportunity in the therapeutic antibody market?

Drug Discovery World

What you will learn: Where is the opportunity in the mAb market and where is the market heading? What are the main drivers and challenges for the market in the next ten years? The post Where is the opportunity in the therapeutic antibody market? The post Where is the opportunity in the therapeutic antibody market?